Contact number
+1 312 372 2000Provided by McDermott Will & Emery LLP
The New York healthcare team (and its market leading transactional health focus) is an important extension of McDermott’s healthcare practice. The New York team retains a strong presence in the local market, performing innovative work and major transactions. The team also has the distinct advantage of being able to draw upon the best legal health talent operating out of its New York city base and further, the gold-standard capabilities of the McDermott national healthcare platform.
McDermott are also, undeniably, the most active firm in healthcare private equity transactions, centering our private equity work in New York. Much of our Health PE work is based out of our New York office, with major PE firms and strategics based here and a strong cadre of PE-focused colleagues on our New York team.
Provided by Chambers
McDermott Will & Emery LLP has a highly regarded practice with nationwide capabilities, leveraging an extensive network of offices to advise on significant mandates. Represents a variety of clients in the provider and private equity spaces. Offers counsel across a range of healthcare concerns, including big-ticket transactions and state and federal regulations.
Provided by McDermott Will & Emery LLP
McDermott Will & Emery LLP advised Crouse Health System on a potential merger with SUNY Upstate Medical Center.
Provided by Chambers
"McDermott Will & Emery have a great depth of knowledge and are very responsive."
"The team is extremely well versed in our industry."
"The attorneys are quick, thoughtful and very well connected."
"McDermott Will & Emery have a great depth of knowledge and are very responsive."
"The team is extremely well versed in our industry."
"The attorneys are quick, thoughtful and very well connected."
Provided by Chambers
David Ivill advises healthcare companies and investment funds seeking to expand through M&A. He also offers deep expertise in regulatory matters.
"David is very knowledgeable and thoughtful."
Tony Maida comes recommended for his strong fraud and abuse capabilities, which includes advising on external and internal investigations as well as regulatory compliance.
"Tony is a real asset in terms of his knowledge and expertise in the subject area."
"He is an excellent lawyer."
Steven Schnelle advises healthcare companies and investors on a range of corporate, transactional and regulatory matters. He has expertise in the 340B drug pricing program and other payment/billing strategies.
"Steven is great. He is able to navigate very complex situations."
"He is knowledgeable and approachable."
Provided by McDermott Will & Emery LLP